Clinical trial results presented at the Union World Conference on Lung Health in Paris on Wednesday provided evidence to support the use of four new, improved regimens to treat multi-drug resistant tuberculosis or rifampicin-resistant tuberculosis (MDR/RR-TB).  The endTB clinical trial found three new drug regimens that can deliver similar efficacy and safety to conventional treatments … Continue reading Trial Finds Four New Treatment Options for Multi-Drug Resistant Tuberculosis